Concepedia
Statistics
Publications
10
Citations
346
H-Index
Active since
2015
Affiliations
Novartis (Switzerland)(Current)
KU Leuven
Eli Lilly (United States)
Hasselt University
Biogen (United States)
James Bell is an author at Novartis (Switzerland) specializing in clinical trials, study design, and biostatistics.
Publications per year
2015–2025
Choosing Estimands in Clinical Trials: Putting the ICH E9(R1) Into Practice
Bohdana Ratitch, James Bell, Craig Mallinckrodt et al. · Therapeutic Innovation & Regulatory Science · 2020 · 78 citations
Public Health, Biostatistics, Epidemiology +5
Aligning Estimators With Estimands in Clinical Trials: Putting the ICH E9(R1) Guidelines Into Practice
Craig Mallinckrodt, James Bell, G. Liu et al. · Therapeutic Innovation & Regulatory Science · 2020 · 68 citations
Public Health, Biostatistics, Clinical Epidemiology +7
Determinants of oral anticoagulation control in new warfarin patients: analysis using data from Clinical Practice Research Datalink
Ana Filipa Macedo, James Bell, C. McCarron et al. · Thrombosis Research · 2015 · 65 citations · Full text
Medicine, Pharmacotherapy, Clinical Epidemiology +13
Defining Efficacy Estimands in Clinical Trials: Examples Illustrating ICH E9(R1) Guidelines
Bohdana Ratitch, Niti Goel, Craig Mallinckrodt et al. · Therapeutic Innovation & Regulatory Science · 2020 · 39 citations · Full text
Medicine, Pharmacology, Evidence-based Practice +13
Marking 2-Years of New Thinking in Clinical Trials: The Estimand Journey
Christine Fletcher, Nanco Hefting, Melanie Wright et al. · Therapeutic Innovation & Regulatory Science · 2022 · 24 citations · Full text
Medicine, Biostatistics, Clinical Epidemiology +4
1–5 of 10